This study reveals that the hsa_circ_0006692/miR-205-5p/CDK19 axis plays a role in the growth, metastasis, progression, and EMT in NSCLC, which might serve as a prognostic biomarker or a new target for blocking the malignancy of NSCLC. This evidence concerns the gene CDK19 and non-small cell lung carcinoma.